Literature DB >> 20162067

Chemopreventive effect of Cousinia shulabadensis Attar & Ghahraman ethanol extract.

Ahmad R Shahverdi1, Mohammad R Khoramizadeh, Mohammad H Ghahramani, Ardeshir Golyaee, Farideh Attar, Ahmad Ghahraman.   

Abstract

Matrix metalloproteinases (MMPs) play an important role in several pathologic processes such as malignancy in which they facilitate invasion and metastasis and can be targets for anticancer therapies. Here, in this study, we investigated the cytotoxicity effect of Cousinia shulabadensis Attar & Ghahraman extract as well as its impact on MMPs activity using a model of cell line (Fibrosarcoma-Wehi164). To assess anti-invasiveness potentials, a modified zymoanalysis method was used to measure MMP-2 and MMP-9 activities in the conditioned-media. The concentration necessary to produce 50% cell death was >80 microg/ml for ethanol extract of Cousinia shulabadensis, while a 23 microg/ml concentration of the diclofenac sodium produced the same effect. The invasion of WEHI 164 cells was considerably inhibited at concentrations > 20 microg/ml by total plant extract. The total extract of the plant did not show high toxicity at all tested concentrations, but demonstrated significant inhibition of MMP activity in dose-response fashion.

Entities:  

Keywords:  Cousinia shulabadensis; anti-invasive activity; chemoprevention; cytotoxicity; matrix metalloproteinases

Year:  2006        PMID: 20162067      PMCID: PMC2816432     

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  8 in total

1.  Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1.

Authors:  T Sadowski; J Steinmeyer
Journal:  Inflamm Res       Date:  2001-03       Impact factor: 4.575

2.  Inhibition of metalloproteinase activity by fruit extracts.

Authors:  Patricia Tate; Jason God; Robert Bibb; Qi Lu; Lyndon L Larcom
Journal:  Cancer Lett       Date:  2004-08-30       Impact factor: 8.679

Review 3.  Clinical potential of matrix metalloprotease inhibitors in cancer therapy.

Authors:  E I Heath; L B Grochow
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 4.  Human endothelial gelatinases and angiogenesis.

Authors:  M Nguyen; J Arkell; C J Jackson
Journal:  Int J Biochem Cell Biol       Date:  2001-10       Impact factor: 5.085

Review 5.  Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic.

Authors:  W G Stetler-Stevenson; R Hewitt; M Corcoran
Journal:  Semin Cancer Biol       Date:  1996-06       Impact factor: 15.707

6.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

Authors:  C Heussen; E B Dowdle
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

Review 7.  The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.

Authors:  L Jones; P Ghaneh; M Humphreys; J P Neoptolemos
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

Review 8.  The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis.

Authors:  A John; G Tuszynski
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.